Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: AGN-242428 in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial of AGN-242428 for plaque psoriasis was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) [Phase 3]
Phase 3 trial comparing mirikizumab to secukinumab and placebo in moderate-to-severe plaque psoriasis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: International Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of BCD-085 in Various Doses in Patients With Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 trial assessing multiple subcutaneous doses of BCD-085 for plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 trial evaluating a new formulation of risankizumab for safety and efficacy in moderate to severe plaque psoriasis has completed with…
-
FDA approval · 2021-02-24FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approval of a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-01-22FDA Approved: SILIQ — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental Biologics License Application for SILIQ (brodalumab) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Enstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of Color [Phase 4]
Phase 4 trial update evaluating Enstilar Foam for chronic plaque psoriasis in patients with skin of color; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2021-01-06Clinical Trial Update: A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis [Phase 2]
A Phase 2 study evaluating the pharmacokinetics, pharmacodynamics, and safety of bimekizumab in adults with plaque psoriasis has completed a…
-
CLINICAL_TRIALS trial_result · 2020-12-22Clinical Trial Update: A Dose Finding Study of AEB071 Assessing Psoriasis Area and Severity Index in Patients With Plaque Psoriasis [Phase 2]
Phase 2 dose-finding trial evaluating AEB071 in patients with moderate to severe plaque psoriasis has completed.
-
FDA approval · 2020-12-11FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab filed by Janssen Biotech, Inc. The action updates the product's labeling.
-
FDA approval · 2020-12-01FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approves a supplemental application for ustekinumab (Stelara) from Janssen Biotech, Inc., reflecting an approval of changes to its label…
-
CLINICAL_TRIALS trial_result · 2020-11-20Clinical Trial Update: Efficacy and Safety of Sorilux in Maintenance Treatment of Moderate Type Plaque Psoriasis [Phase 4]
Phase 4 trial assessing the efficacy and safety of Sorilux for maintenance treatment in moderate plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2020-11-19Clinical Trial Update: Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis [Phase 2]
Phase 2 trial evaluating safety and efficacy of different doses of bimekizumab in chronic plaque psoriasis completed with results posted.
-
FDA approval · 2020-10-16FDA Approved: ENSTILAR — Supplemental Application (LEO Pharma Inc.)
FDA approved a supplemental application for ENSTILAR, a calcipotriene and betamethasone dipropionate combination, from LEO Pharma Inc.
-
CLINICAL_TRIALS trial_result · 2020-10-09Clinical Trial Update: The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab [Phase 4]
Phase 4 trial update evaluating the safety and efficacy of etanercept in psoriasis patients unresponsive to adalimumab.
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis [Phase 4]
A Phase 4 clinical trial assessing patient satisfaction with twice-daily dosing of DFD-01 in adults with moderate plaque psoriasis has compl…
-
FDA approval · 2020-09-02FDA Approved: CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' generic calcipotriene and betamethasone dipropionate topical combination for plaque psoriasis.
-
CLINICAL_TRIALS trial_result · 2020-08-28Clinical Trial Update: An Efficacy, Safety, and Pharmacokinetics Study of Subcutaneously Administered Ustekinumab in the Treatment of Moderate to Severe Chronic Plaque Psoriasis in Pediatric Participants Greater Than or Equal to 6 to Less Than 12 Years of Age [Phase 3]
Phase 3 trial evaluating subcutaneously administered ustekinumab for moderate to severe chronic plaque psoriasis in pediatric patients aged …
-
FDA approval · 2020-08-28FDA Approved: CLOBETASOL PROPIONATE CREAM USP, 0.05% CLOBETASOL PROPIONATE CREAM USP, 0.05% — Original Application (Northstar Rx LLC)
FDA approved Northstar Rx LLC's generic clobetasol propionate cream 0.05% (ANDA212982), a potent topical corticosteroid indicated for inflam…
-
FDA approval · 2020-08-27FDA Approved: HALOBETASOL PROPIONATE — Supplemental Application (Coral Way Pharma, LLC)
FDA approved a supplemental application for halobetasol propionate filed by Coral Way Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-26Clinical Trial Update: The Effect of Enstilar Versus Vehicle on Target Lesions in Moderate Plaque Type Psoriasis Patients [Phase 4]
Phase 4 trial comparing Enstilar to vehicle on target lesions in adults with moderate plaque psoriasis; results completed and posted.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 trial updates safety and efficacy of IDP-118 in treating plaque psoriasis; results posted after completion in 2020.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy of IDP-118 Lotion to Ultravate® in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 trial updates safety and efficacy of IDP-118 Lotion compared with Ultravate for plaque psoriasis; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy of IDP-118 in the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 clinical trial update on IDP-118 for plaque psoriasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-08-20Clinical Trial Update: Safety and Efficacy of IDP 118 in the Treatment of Plaque Psoriasis [Phase 2]
Phase 2 clinical trial update on IDP 118 for plaque psoriasis showing safety and efficacy results. Completed with results posted in 2020.